.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
US Department of Justice
Harvard Business School
Healthtrust
Merck
Cantor Fitzgerald
Teva
Argus Health
Colorcon

Generated: December 15, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 97401042

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Genzyme CorpCAPRELSAvandetanibTABLET;ORAL022405-001Apr 6, 2011RXYesNo► Subscribe► Subscribe► SubscribeYY
Genzyme CorpCAPRELSAvandetanibTABLET;ORAL022405-002Apr 6, 2011RXYesYes► Subscribe► Subscribe► SubscribeYY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist